{
  "id": "nclex_ngn_bowtie_hf_hyperk_001",
  "questionType": "bowtie",
  "stem": "The nurse is caring for a client admitted with acute decompensated heart failure. Review the electronic health record (EHR). Complete the diagram by selecting the appropriate options from the choices provided.",
  "ehrTabs": [
    {
      "id": "tab1",
      "label": "Nurses' Notes",
      "content": "A 72-year-old male with a history of heart failure with reduced ejection fraction (HFrEF, EF 25%) presents to the emergency department at 0800 with severe shortness of breath, orthopnea (sleeps on 3 pillows), and a productive cough with pink-tinged sputum. States he has gained 15 lbs (6.8 kg) in the last week. He reports running out of his 'water pills' about 5 days ago and had difficulty getting a ride to the pharmacy. Client appears anxious, diaphoretic, and is using accessory muscles to breathe. Auscultation reveals crackles throughout all lung fields. SBAR: Situation: 72-year-old male with HFrEF presenting with acute decompensated heart failure, severe shortness of breath, and hyperkalemia. Background: History of HFrEF (EF 25%), medication non-adherence due to running out of diuretics. Assessment: BP 88/56, HR 118, RR 28, SpO2 93% on 4L NC, K+ 7.1 mEq/L, BUN 88 mg/dL, Creatinine 3.9 mg/dL, Lactate 4.2 mmol/L. Crackles throughout lung fields. Anxious and diaphoretic. Recommendation: Administer IV calcium gluconate for hyperkalemia, prepare for emergent hemodialysis, withhold spironolactone, continuous cardiac monitoring, and strict urine output monitoring."
    },
    {
      "id": "tab2",
      "label": "Vital Signs",
      "content": [
        {
          "time": "0800",
          "BP": "110/72",
          "HR": "98",
          "RR": "26",
          "SpO2": "92% on 2L NC",
          "Temp": "37.1 C (98.8 F)"
        },
        {
          "time": "1000",
          "BP": "102/68",
          "HR": "105",
          "RR": "28",
          "SpO2": "93% on 4L NC",
          "Temp": "37.2 C (99.0 F)"
        },
        {
          "time": "1200",
          "BP": "88/56",
          "HR": "118",
          "RR": "28",
          "SpO2": "93% on 4L NC",
          "Temp": "37.0 C (98.6 F)"
        }
      ]
    },
    {
      "id": "tab3",
      "label": "Laboratory Results",
      "content": [
        {
          "test": "Potassium",
          "value": "7.1 mEq/L",
          "range": "3.5-5.0 mEq/L",
          "flag": "Critical High"
        },
        {
          "test": "BNP",
          "value": "6,200 pg/mL",
          "range": "<100 pg/mL",
          "flag": "High"
        },
        {
          "test": "BUN",
          "value": "88 mg/dL",
          "range": "7-20 mg/dL",
          "flag": "High"
        },
        {
          "test": "Creatinine",
          "value": "3.9 mg/dL",
          "range": "0.6-1.2 mg/dL",
          "flag": "High"
        },
        {
          "test": "Lactate",
          "value": "4.2 mmol/L",
          "range": "0.5-2.2 mmol/L",
          "flag": "High"
        },
        {
          "test": "Troponin T, high sensitivity",
          "value": "0.02 ng/mL",
          "range": "<0.04 ng/mL",
          "flag": "Normal"
        }
      ]
    },
    {
      "id": "tab4",
      "label": "MAR",
      "content": [
        {
          "medication": "Furosemide 80 mg IV BID",
          "notes": "Next dose due at 1400"
        },
        {
          "medication": "Lisinopril 10 mg PO Daily",
          "notes": "Due now. Held by provider due to hypotension."
        },
        {
          "medication": "Spironolactone 25 mg PO Daily",
          "notes": "Due now."
        },
        {
          "medication": "Metoprolol Succinate 50 mg PO Daily",
          "notes": "Due now. Held by provider due to hypotension/bradycardia risk."
        }
      ]
    }
  ],
  "bowtie": {
    "prompt": "The nurse recognizes the client is developing **[Potential Condition]**. The nurse should **[Action to Take]** and monitor the client's **[Parameters to Monitor]** and **[Parameters to Monitor]**. The nurse should also **[Actions to Take]** and **[Actions to Take]**.",
    "options": {
      "potentialConditions": [
        "Cardiogenic Shock",
        "Pulmonary Embolism",
        "Septic Shock",
        "Acute Coronary Syndrome",
        "Anaphylactic Reaction"
      ],
      "actionsToTake": [
        "Administer IV Calcium Gluconate",
        "Administer IV furosemide",
        "Initiate dobutamine infusion",
        "Administer oral potassium supplement",
        "Request a chest x-ray"
      ],
      "parametersToMonitor": [
        "Continuous cardiac monitoring",
        "Urine output",
        "Blood glucose levels",
        "Daily weight",
        "Abdominal girth"
      ],
      "leftActionsToTake": [
        "Withhold the scheduled spironolactone",
        "Prepare for emergent hemodialysis",
        "Encourage oral fluid intake",
        "Administer the held lisinopril",
        "Place the client in a high-Fowler's position"
      ]
    },
    "solution": {
      "potentialCondition": "Cardiogenic Shock",
      "actionToTake": "Administer IV Calcium Gluconate",
      "parametersToMonitor": [
        "Continuous cardiac monitoring",
        "Urine output"
      ],
      "leftActionsToTake": [
        "Withhold the scheduled spironolactone",
        "Prepare for emergent hemodialysis"
      ]
    }
  },
  "rationale": {
    "correct": "The client is exhibiting signs of cardiogenic shock, a life-threatening condition where the heart cannot pump enough blood to meet the body's needs. This is evidenced by hypotension (BP 88/56 mmHg), tachycardia (HR 118 bpm), elevated lactate (4.2 mmol/L), and signs of pulmonary edema (crackles, pink-tinged sputum). The elevated BNP (6200 pg/mL) confirms heart failure, while the elevated BUN (88 mg/dL) and creatinine (3.9 mg/dL) indicate acute kidney injury (AKI), likely due to decreased renal perfusion secondary to the failing heart (cardiorenal syndrome). The critical hyperkalemia (K+ 7.1 mEq/L) poses an immediate threat of fatal cardiac dysrhythmias. The pathophysiology of hyperkalemia involves the disruption of the normal resting membrane potential of cardiac cells, leading to increased excitability and potentially lethal arrhythmias like ventricular fibrillation or asystole. Calcium gluconate does not lower potassium levels but stabilizes the cardiac cell membrane, reducing the risk of dysrhythmias. Therefore, the priority is to administer IV calcium gluconate to protect the heart. Simultaneously, the nurse must recognize that administering spironolactone, a potassium-sparing diuretic, is contraindicated and could be fatal ('SAFETY STOP'). Spironolactone inhibits aldosterone, leading to increased potassium retention. The definitive treatments for severe hyperkalemia and AKI with fluid overload are emergent hemodialysis to remove excess potassium and fluid, and withholding medications that could worsen hyperkalemia. Continuous cardiac monitoring is essential to detect and treat any dysrhythmias caused by hyperkalemia. Strict urine output monitoring is crucial to assess renal perfusion and the effectiveness of interventions. Clinical Pearl: In patients with heart failure and AKI, avoid nephrotoxic medications (NSAIDs, ACE inhibitors/ARBs in severe cases) and monitor renal function closely.",
    "incorrect": "Administering furosemide in the setting of severe AKI and hypotension may not be effective and could worsen renal function by further reducing renal perfusion. Furosemide, a loop diuretic, works by inhibiting sodium and chloride reabsorption in the loop of Henle, leading to increased water excretion. However, in AKI, the kidneys may not respond adequately to furosemide, and the resulting hypovolemia can exacerbate hypotension and renal injury. Initiating dobutamine, a beta-1 adrenergic agonist, might be considered later to improve cardiac output, but it does not address the immediate life threat of hyperkalemia. Dobutamine increases myocardial contractility and heart rate, potentially increasing myocardial oxygen demand. Administering potassium is absolutely contraindicated and dangerous, as it would further elevate the already critically high potassium level, increasing the risk of cardiac arrest. A chest x-ray is not the priority action, as the clinical presentation and lab results already strongly suggest cardiogenic pulmonary edema. Monitoring daily weight and abdominal girth are important for chronic HF management but are not relevant to this acute, life-threatening situation. Administering held medications like lisinopril (ACE inhibitor) or encouraging fluids would worsen the client's hemodynamic instability and fluid overload. ACE inhibitors can worsen hyperkalemia, and increased fluid intake would exacerbate pulmonary edema. Clinical Pearl: Always prioritize addressing life-threatening electrolyte imbalances before focusing on other aspects of heart failure management.",
    "answerBreakdown": [
      {
        "label": "Potential Condition",
        "content": "Cardiogenic Shock",
        "isCorrect": true,
        "justification": "Correct. The client's hypotension (BP 88/56), tachycardia (HR 118), elevated lactate (4.2 mmol/L), and signs of pulmonary edema (crackles, pink-tinged sputum) in the context of acute heart failure strongly indicate cardiogenic shock. The heart is failing to pump enough blood to meet the body's needs, leading to tissue hypoperfusion and end-organ damage. Clinical Pearl: Cardiogenic shock often presents with a constellation of findings, including hypotension, tachycardia, pulmonary congestion, and altered mental status. Early recognition and intervention are crucial to improve outcomes."
      },
      {
        "label": "Potential Condition",
        "content": "Septic Shock",
        "isCorrect": false,
        "justification": "Incorrect. The client lacks a clear source of infection and does not have a fever. While septic shock can also cause hypotension and tachycardia, the absence of infectious signs and the presence of pulmonary edema make cardiogenic shock more likely. Clinical Pearl: Septic shock is characterized by hypotension, tachycardia, and signs of infection, such as fever, elevated white blood cell count, and purulent drainage."
      },
      {
        "label": "Potential Condition",
        "content": "Pulmonary Embolism",
        "isCorrect": false,
        "justification": "Incorrect. While PE can cause shortness of breath and hypotension, the widespread crackles, pink sputum, and massively elevated BNP are more indicative of cardiogenic pulmonary edema. A PE would typically present with more acute onset of dyspnea and pleuritic chest pain. Clinical Pearl: Pulmonary embolism should be suspected in patients with sudden onset of dyspnea, chest pain, and risk factors for thromboembolism, such as recent surgery or prolonged immobilization."
      },
      {
        "label": "Action to Take",
        "content": "Administer IV Calcium Gluconate",
        "isCorrect": true,
        "justification": "Correct. This is the first-line, immediate intervention for severe hyperkalemia with potential ECG changes (though ECG not provided, K+ this high warrants treatment). Calcium gluconate stabilizes the cardiac membrane, reducing the risk of life-threatening dysrhythmias. Clinical Pearl: Calcium gluconate does not lower potassium levels but protects the heart from the effects of hyperkalemia. It is a temporizing measure while other treatments to lower potassium are initiated."
      },
      {
        "label": "Action to Take",
        "content": "Administer IV furosemide",
        "isCorrect": false,
        "justification": "Incorrect. While furosemide is used in heart failure to reduce fluid overload, it is less likely to be effective in severe AKI (Cr 3.9) and giving it to a hypotensive patient (BP 88/56) can worsen perfusion and renal injury. Clinical Pearl: In patients with AKI, diuretics may not be effective and can even worsen renal function. Consider alternative strategies for fluid removal, such as ultrafiltration or hemodialysis."
      },
      {
        "label": "Action to Take",
        "content": "Initiate dobutamine infusion",
        "isCorrect": false,
        "justification": "Incorrect. While an inotrope like dobutamine may be needed to treat the cardiogenic shock by increasing cardiac output, stabilizing the cardiac membrane from hyperkalemia is the absolute first priority. Dobutamine can also increase myocardial oxygen demand, which may be detrimental in a patient with underlying heart failure. Clinical Pearl: Inotropic support should be used cautiously in cardiogenic shock, as it can increase myocardial oxygen demand and potentially worsen ischemia."
      },
      {
        "label": "Parameters to Monitor",
        "content": "Continuous cardiac monitoring",
        "isCorrect": true,
        "justification": "Correct. Hyperkalemia (K+ 7.1) places the client at extremely high risk for life-threatening arrhythmias (e.g., peaked T waves, ventricular fibrillation, asystole). Continuous ECG monitoring is essential to detect and treat any dysrhythmias promptly. Clinical Pearl: Hyperkalemia can cause a variety of ECG changes, including peaked T waves, prolonged PR interval, widened QRS complex, and ultimately, ventricular fibrillation or asystole."
      },
      {
        "label": "Parameters to Monitor",
        "content": "Urine output",
        "isCorrect": true,
        "justification": "Correct. Urine output is a critical indicator of renal perfusion and the severity of the AKI. Monitoring the response to treatment, including fluid resuscitation and potassium-lowering therapies, is vital. Clinical Pearl: Oliguria (decreased urine output) is a common sign of AKI and can indicate inadequate renal perfusion."
      },
      {
        "label": "Parameters to Monitor",
        "content": "Daily weight",
        "isCorrect": false,
        "justification": "Incorrect. While important for managing fluid balance in heart failure over days, it is not an immediate parameter for monitoring this acute crisis of shock and hyperkalemia. Clinical Pearl: Daily weights are useful for assessing long-term fluid balance in heart failure but are not as helpful in the acute management of cardiogenic shock."
      },
      {
        "label": "Actions to Take",
        "content": "Withhold the scheduled spironolactone",
        "isCorrect": true,
        "justification": "Correct. This is the critical 'DON'T PROCEED' / 'SAFETY STOP' action. Spironolactone is a potassium-sparing diuretic. Administering it to a client with a potassium of 7.1 mEq/L would be lethal. Clinical Pearl: Always review the patient's medication list and laboratory results before administering any medication, especially in patients with electrolyte imbalances or renal dysfunction."
      },
      {
        "label": "Actions to Take",
        "content": "Prepare for emergent hemodialysis",
        "isCorrect": true,
        "justification": "Correct. This is the definitive treatment to correct severe hyperkalemia, metabolic acidosis, and fluid overload caused by AKI. The nurse must anticipate this and prepare the client for the procedure. Clinical Pearl: Hemodialysis is the most effective way to rapidly lower potassium levels and remove excess fluid in patients with severe hyperkalemia and AKI."
      },
      {
        "label": "Actions to Take",
        "content": "Place the client in a high-Fowler's position",
        "isCorrect": false,
        "justification": "Incorrect. While a standard comfort measure for dyspnea in HF, this client is likely already in this position. It does not address the root causes of shock and hyperkalemia, which are the priorities. Clinical Pearl: While positioning can improve comfort and breathing, it is not a substitute for addressing the underlying pathophysiology of the patient's condition."
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyzing",
    "cjmmStep": "Recognize Cues, Analyze Cues, Prioritize Hypotheses, Take Actions",
    "nclexCategory": "Physiological Adaptation",
    "secondaryCategory": "Reduction of Risk Potential",
    "difficulty": "Hard",
    "topicTags": [
      "Acute Heart Failure",
      "Cardiogenic Shock",
      "Hyperkalemia",
      "Acute Kidney Injury",
      "Medication Safety",
      "Contraindication",
      "Social Determinants of Health"
    ]
  },
  "sentinelStatus": "healed_v2026_v8"
}